VIM and breast carcinoma: In breast cancer, Datar and Schalper showed that increased vimentin/reduced E-cadherin is associated with PD-L1 upregulation and escape of the tumor from the immune system, while downregulation of PD-L1 correlates with low expression of mesenchymal phenotype in breast cancer.